Integration of metabolomics and transcriptomics in nanotoxicity studies

키워드

참고문헌 (76)

1. Stark WJ, "Nanoparticles in biological systems", Angew Chem Int Ed Engl, 50, pp.1242~1258 (2011)[DOI]
2. Havel H, "Nanomedicines: From Bench to Bedside and Beyond", AAPS J, 18, pp.1373~1378 (2016)[DOI]
3. Yang Y, "Advances in silica based nanoparticles for targeted cancer therapy", Nanomedicine, 12, pp.317~332 (2016)[DOI]
4. Deng R, "Nanoparticle interactions with co-existing contaminants: Joint toxicity, bioaccumulation and risk", Nanotoxicology, pp.1~56 (2017)
5. Vayssieres L, "Size Tailoring of Magnetite Particles Formed by Aqueous Precipitation: An Example of Thermodynamic Stability of Nanometric Oxide Particles", J Colloid Interface Sci, 205, pp.205~212 (1998)[DOI]
6. Auffan M, "Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective", Nat Nanotechnol, 4, pp.634~641 (2009)[DOI]
7. Krug HF, "Nanotoxicology: an interdisciplinary challenge", Angew Chem Int Ed Engl, 50, pp.1260~1278 (2011)[DOI]
8. Bouallegui Y, "Histopathology and analyses of inflammation intensity in the gills of mussels exposed to silver nanoparticles: role of nanoparticle size, exposure time, and uptake pathways", Toxicol Mech Methods, pp.1~10 (2017)
9. Service RF, "Is nanotechnology dangerous?", Science, 290, pp.1526~1527 (2000)[DOI]
10. Boyes WK, "A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials", Crit Rev Toxicol, pp.1~44 (2017)
11. Schnackenberg LK, "Metabolomics techniques in nanotoxicology studies", Methods Mol Biol, 926, pp.141~156 (2012)
12. Masoud R, "Titanium Dioxide Nanoparticles Increase Superoxide Anion Production by Acting on NADPH Oxidase", PLoS One, 10, pp.e0144829~ (2015)[DOI]
13. Tuncbag N, "Network-Based Interpretation of Diverse High-Throughput Datasets through the Omics Integrator Software Package", PLoS Comput Biol, 12, pp.e1004879~ (2016)[DOI]
14. Norris JL, "Integrated, High-Throughput, Multiomics Platform Enables Data-Driven Construction of Cellular Responses and Reveals Global Drug Mechanisms of Action", J Proteome Res, 16, pp.1364~1375 (2017)[DOI]
15. Hasin Y, "Multi-omics approaches to disease", Genome Biol, 18, pp.83~ (2017)[DOI]
16. Hu X, "Knowledge gaps between nanotoxicological research and nanomaterial safety", Environ Int, 94, pp.8~23 (2016)[DOI]
17. Reyes VC, "Genome-wide assessment in Escherichia coli reveals time-dependent nanotoxicity paradigms", ACS Nano, 6, pp.9402~9415 (2012)[DOI]
18. Bo Y, "Metabolomic analysis on the toxicological effects of TiO(2) nanoparticles in mouse fibroblast cells: from the perspective of perturbations in amino acid metabolism", Toxicol Mech Methods, 24, pp.461~469 (2014)[DOI]
19. Verano-Braga T, "Insights into the cellular response triggered by silver nanoparticles using quantitative proteomics", ACS Nano, 8, pp.2161~2175 (2014)[DOI]
20. Zhao Y, "Differential Regulation of Gene and Protein Expression by Zinc Oxide Nanoparticles in Hen's Ovarian Granulosa Cells: Specific Roles of Nanoparticles", PLoS One, 10, pp.e0140499~ (2015)[DOI]
21. Prohaska SJ, "The use and abuse of -omes", Methods Mol Biol, 719, pp.173~196 (2011)
22. Van Assche R, "Integrating -Omics: Systems Biology as Explored Through C. elegans Research", J Mol Biol, 427, pp.3441~3451 (2015)[DOI]
23. Sun YV, "Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases", Adv Genet, 93, pp.147~190 (2016)
24. Hood L, "Leroy Hood expounds the principles, practice and future of systems biology", Drug Discov Today, 8, pp.436~438 (2003)[DOI]
25. Hood L, "Systems biology: integrating technology, biology, and computation", Mech Ageing Dev, 124, pp.9~16 (2003)[DOI]
26. Palsson B, "The challenges of integrating multi-omic data sets", Nat Chem Biol, 6, pp.787~789 (2010)[DOI]
27. Shim W, "Analysis of changes in gene expression and metabolic profiles induced by silica-coated magnetic nanoparticles", ACS Nano, 6, pp.7665~7680 (2012)[DOI]
28. Phukan G, "Silica-coated magnetic nanoparticles impair proteasome activity and increase the formation of cytoplasmic inclusion bodies in vitro", Sci Rep, 6, pp.29095~ (2016)[DOI]
29. Kim JS, "Toxicity and tissue distribution of magnetic nanoparticles in mice", Toxicol Sci, 89, pp.338~347 (2006)[DOI]
30. Park KS, "Characterization, in vitro cytotoxicity assessment, and in vivo visualization of multimodal, RITC-labeled, silica-coated magnetic nanoparticles for labeling human cord blood-derived mesenchymal stem cells", Nanomedicine, 6, pp.263~276 (2010)[DOI]
31. Beck GR Jr, "Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo", Nanomedicine, 8, pp.793~803 (2012)[DOI]
32. Fan TW, "Integrating metabolomics and transcriptomics for probing SE anticancer mechanisms", Drug Metab Rev, 38, pp.707~732 (2006)[DOI]
33. Rehrauer H, "Blind spots of quantitative RNA-seq: the limits for assessing abundance, differential expression, and isoform switching", BMC Bioinformatics, 14, pp.370~ (2013)[DOI]
34. Evans TG, "Considerations for the use of transcriptomics in identifying the 'genes that matter' for environmental adaptation", J Exp Biol, 218, pp.1925~1935 (2015)[DOI]
35. Gibney MJ, "Metabolomics in human nutrition: opportunities and challenges", Am J Clin Nutr, 82, pp.497~503 (2005)[DOI]
36. Moseley HN, "Error Analysis and Propagation in Metabolomics Data Analysis", Comput Struct Biotechnol J, 4 (2013)
37. Johnson CH, "Metabolomics: beyond biomarkers and towards mechanisms", Nat Rev Mol Cell Biol, 17, pp.451~459 (2016)[DOI]
38. Fukusaki E, "Application of Metabolomics for High Resolution Phenotype Analysis", Mass Spectrom (Tokyo), 3, pp.S0045~ (2014)[DOI]
39. Zlatkis A, "The role of organic volatile profiles in clinical diagnosis", Clin Chem, 27, pp.789~797 (1981)
40. Karlic H, "Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells", Cancer Genet, 208, pp.241~252 (2015)[DOI]
41. Zabala-Letona A, "mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer", Nature, 547, pp.109~113 (2017)[DOI]
42. Robertson DG, "Metabolomics in toxicology: preclinical and clinical applications", Toxicol Sci, 120(Suppl 1), pp.S146~S170 (2011)[DOI]
43. Pan Z, "Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics", Anal Bioanal Chem, 387, pp.525~527 (2007)[DOI]
44. Shah SH, "Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function", Circulation, 126, pp.1110~1120 (2012)[DOI]
45. Smith CA, "XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification", Anal Chem, 78, pp.779~787 (2006)[DOI]
46. Dudley E, "Targeted metabolomics and mass spectrometry", Adv Protein Chem Struct Biol, 80, pp.45~83 (2010)
47. Paik MJ, "Pattern recognition analysis of polyamines in the plasma of rat models with adenovirus infection", Clin Chim Acta, 380, pp.228~231 (2007)[DOI]
48. Paik MJ, "The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats", Clin Chim Acta, 402, pp.25~30 (2009)[DOI]
49. Paik MJ, "Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy", Clin Chim Acta, 411, pp.1532~1535 (2010)[DOI]
50. Shin TH, "Restoration of Polyamine Metabolic Patterns in In Vivo and In Vitro Model of Ischemic Stroke following Human Mesenchymal Stem Cell Treatment", Stem Cells Int, 2016, pp.4612531~ (2016)
51. Shin TH, "Quality and freshness of human bone marrow-derived mesenchymal stem cells decrease over time after trypsinization and storage in phosphate-buffered saline", Sci Rep, 7, pp.1106~ (2017)[DOI]
52. Lv M, "Metabolomics techniques for nanotoxicity investigations", Bioanalysis, 7, pp.1527~1544 (2015)[DOI]
53. Vatakuti S, "Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices", Chem Res Toxicol, 29, pp.342~351 (2016)[DOI]
54. Kohonen P, "A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury", Nat Commun, 8, pp.15932~ (2017)[DOI]
55. Dix DJ, "A framework for the use of genomics data at the EPA", Nat Biotechnol, 24, pp.1108~1111 (2006)[DOI]
56. Williams TD, "The toxicological application of transcriptomics and epigenomics in zebrafish and other teleosts", Brief Funct Genomics, 13, pp.157~171 (2014)[DOI]
57. Cheng F, "In vitro transcriptomic prediction of hepatotoxicity for early drug discovery", J Theor Biol, 290, pp.27~36 (2011)[DOI]
58. Zhang M, "Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?", Chem Res Toxicol, 25, pp.122~129 (2012)[DOI]
59. Chen M, "Toward predictive models for drug-induced liver injury in humans: are we there yet", Biomark Med, 8, pp.201~213 (2014)[DOI]
60. Chen S, "Sertraline induces endoplasmic reticulum stress in hepatic cells", Toxicology, 322, pp.78~88 (2014)[DOI]
61. Otava M, "Identification of in vitro and in vivo disconnects using transcriptomic data", BMC Genomics, 16, pp.615~ (2015)[DOI]
62. Lorscheidt S, "Safety assessment of nanoparticles for drug delivery by means of classic in vitro assays and beyond", Expert Opin Drug Deliv, 13, pp.1545~1558 (2016)[DOI]
63. Hood L, "Systems biology at the Institute for Systems Biology", Brief Funct Genomic Proteomic, 7, pp.239~248 (2008)[DOI]
64. Shah SH, "Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease", Circ Cardiovasc Genet, 8, pp.410~419 (2015)[DOI]
65. Rebollar EA, "Using "Omics" and Integrated Multi-Omics Approaches to Guide Probiotic Selection to Mitigate Chytridiomycosis and Other Emerging Infectious Diseases", Front Microbiol, 7, pp.68~ (2016)
66. Hartiala JA, "Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease", Nat Commun, 7, pp.10558~ (2016)[DOI]
67. Kim J, "Toward Systems Understanding of Leaf Senescence: An Integrated Multi-Omics Perspective on Leaf Senescence Research", Mol Plant, 9, pp.813~825 (2016)[DOI]
68. Berg KCG, "Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies", Mol Cancer, 16, pp.116~ (2017)
69. Thakor AS, "Nanooncology: the future of cancer diagnosis and therapy", CA Cancer J Clin, 63, pp.395~418 (2013)[DOI]
70. Chen R, "Endoplasmic reticulum stress induced by zinc oxide nanoparticles is an earlier biomarker for nanotoxicological evaluation", ACS Nano, 8, pp.2562~2574 (2014)[DOI]
71. Matysiak M, "Proteomic approach to nanotoxicity", J Proteomics, 137, pp.35~44 (2016)[DOI]
72. Amemiya Y, "Novel detection system for biomolecules using nano-sized bacterial magnetic particles and magnetic force microscopy", J Biotechnol, 120, pp.308~314 (2005)[DOI]
73. Jun YW, "Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences", Acc Chem Res, 41, pp.179~189 (2008)[DOI]
74. Larsen BA, "Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes", Nanotechnology, 19, pp.265102~ (2008)[DOI]
75. Kang T, "Surface design of magnetic nanoparticles for stimuliresponsive cancer imaging and therapy", Biomaterials, 136, pp.98~114 (2017)[DOI]
76. Yoon TJ, "Multifunctional nanoparticles possessing a "magnetic motor effect" for drug or gene delivery", Angew Chem Int Ed Engl, 44, pp.1068~1071 (2005)[DOI]

관련 논문AI추천